The primary objective of this study was to estimate the impact on costs, time, and productivity of incorporating the automation of the HER2 ISH technique combined with IDP in breast cancer diagnosis, including automated equipment, slide scanners, pathology software, and artificial intelligence algorithms. The gene discussed is ERBB2; the disease is breast carcinoma.